Acute interstitial nephritis associated with immune checkpoint inhibitors: a single-centre experience

BACKGROUND: Checkpoint inhibitors (CPIs) are used to treat solid organ metastatic malignancies. They act by triggering a vigorous immune response against tumoural cells, preventing their proliferation and metastasis. However, this is not a selective response and can cause immune-related adverse even...

Descripción completa

Detalles Bibliográficos
Autores principales: Oleas, Diana, Bolufer, Mónica, Agraz, Irene, Felip, Enriqueta, Muñoz, Eva, Gabaldón, Alejandra, Bury, Roxana, Espinel, Eugenia, Serón, Daniel, García-Carro, Clara, Soler, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247740/
https://www.ncbi.nlm.nih.gov/pubmed/34221369
http://dx.doi.org/10.1093/ckj/sfaa008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8247740/
https://www.ncbi.nlm.nih.gov/pubmed/34221369
http://dx.doi.org/10.1093/ckj/sfaa008

Ejemplares similares